Detalhe da pesquisa
1.
Long-term analysis of the RiBVD phase II trial reveals the unfavorable impact of TP53 mutations and hypoalbuminemia in older adults with mantle cell lymphoma; for the LYSA group.
Haematologica
; 2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38031755
2.
Maintenance with daratumumab or observation following treatment with bortezomib, thalidomide, and dexamethasone with or without daratumumab and autologous stem-cell transplant in patients with newly diagnosed multiple myeloma (CASSIOPEIA): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(10): 1378-1390, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34529931
3.
Bortezomib, thalidomide, and dexamethasone with or without daratumumab before and after autologous stem-cell transplantation for newly diagnosed multiple myeloma (CASSIOPEIA): a randomised, open-label, phase 3 study.
Lancet
; 394(10192): 29-38, 2019 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31171419
4.
A phase 2 study of rituximab, bendamustine, bortezomib and dexamethasone for first-line treatment of older patients with mantle cell lymphoma.
Haematologica
; 104(1): 138-146, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171024
5.
Haemolytic paroxysmal nocturnal haemoglobinuria in patients with myeloid neoplasms: A rare association with specific therapeutic implications.
Br J Haematol
; 201(2): e16-e20, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36807116
6.
Shared clonal IGH rearrangement in BCP-ALL occurring after CLL: pitfalls and implications for MRD monitoring.
Br J Haematol
; 191(3): 506-509, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32754904
7.
Concomitant systemic and central nervous system non-Hodgkin lymphoma: the role of consolidation in terms of high dose therapy and autologous stem cell transplantation. A 60-case retrospective study from LYSA and the LOC network.
Haematologica
; 100(9): 1199-206, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26185174
8.
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study.
J Clin Oncol
; 40(32): 3692-3698, 2022 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35834762
9.
Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy.
J Peripher Nerv Syst
; 16(3): 180-5, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-22003932
10.
Bronchial fistula associated with sunitinib in a patient previously treated with radiation therapy.
Ann Pharmacother
; 44(2): 383-6, 2010 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-20118139
11.
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients 60 Years of Age and Younger: Results of the Intergroup ANOCEF-GOELAMS Randomized Phase II PRECIS Study.
J Clin Oncol
; 37(10): 823-833, 2019 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30785830
12.
Multi-drug resistance mediated by P-glycoprotein overexpression is not correlated with ZAP-70/CD38 expression in B-cell chronic lymphocytic leukemia.
Leuk Lymphoma
; 48(8): 1556-60, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17701587
13.
Does bendamustine impact the mobilization of peripheral blood stem cells? A multicenter retrospective study of 23 cases.
Leuk Lymphoma
; 57(5): 1149-53, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26879408
14.
Bendamustine for the treatment of relapsed or refractory peripheral T cell lymphomas: A French retrospective multicenter study.
Oncotarget
; 7(51): 85573-85583, 2016 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-27458168
15.
ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.
PLoS One
; 9(1): e85362, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24465546
16.
Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial.
Blood
; 104(10): 3028-37, 2004 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15256423